# Examining the Role of Transrectal High Intensity Focused Ultrasound (HIFU) in Rectal Pelvic Cancer

> **NCT01097239** · PHASE1,PHASE2 · WITHDRAWN · sponsor: **Imperial College London**

## Conditions studied

- Rectal Cancer
- Ovarian Cancer
- Endometrial Cancer
- Vaginal Cancer
- Cervical Cancer

## Interventions

- **DEVICE:** Sonablate 500 (High Intensity Focused Ultrasound (HIFU))

## Key facts

- **NCT ID:** NCT01097239
- **Lead sponsor:** Imperial College London
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2009-11
- **Primary completion:** 2018-09
- **Final completion:** 2018-09
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Failure to recruit.
- **Last updated:** 2020-11-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01097239

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01097239, "Examining the Role of Transrectal High Intensity Focused Ultrasound (HIFU) in Rectal Pelvic Cancer". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01097239. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*